Pharmaceutical

Prokarium bolsters IP portfolio with two new US patents

UK-based biopharmaceutical company Prokarium has received two Notices of Allowance from the US Patent and Trademark Office.

Nov 5, 2024 - 06:00
Prokarium bolsters IP portfolio with two new US patents
UK-based biopharmaceutical company Prokarium has received two Notices of Allowance from the US Patent and Trademark Office.
Read the original article

Tags:

Previous Article

US Election: In close race, tiny Senate majority, not President, will hold power

Next Article

FDA grants fast track status to FELIQS’s FLQ-101 to prevent ROP

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Capstan secures $175m Series B funds for CAR-T therapy

Capstan secures $175m Series B funds for CAR-T therapy

Mar 22, 2024

FDA rejects Alvotech’s BLA for Stelara biosimilar

FDA rejects Alvotech’s BLA for Stelara biosimilar

Oct 13, 2023

Hearing aids may slow mental decline in those at higher risk of dementia, study finds

Hearing aids may slow mental decline in those at higher...

Jul 18, 2023